These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9723330)
21. Heart transplantation in females. Esmore D; Keogh A; Spratt P; Jones B; Chang V J Heart Lung Transplant; 1991; 10(3):335-41. PubMed ID: 1854761 [TBL] [Abstract][Full Text] [Related]
22. Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum. Boucek MM; Pietra B; Sondheimer H; Luna M; Shaffer E; Hall P; Campbell D Transplant Proc; 1997 Dec; 29(8A):16S-20S. PubMed ID: 9414669 [No Abstract] [Full Text] [Related]
27. Incidence and impact of acute rejection episodes on short- and long-term graft survival in recipients of simultaneous pancreas-kidney transplantation. Cantarovich D; Giral M; Josien R; Karam G; Hourmant M; Dantal J; Blancho G; Soulillou JP Transplant Proc; 1995 Feb; 27(1):1319. PubMed ID: 7878897 [No Abstract] [Full Text] [Related]
28. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation. Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180 [No Abstract] [Full Text] [Related]
29. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation. Reissi D; Bardideh A; Samadzadeh B; Razi A Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875 [No Abstract] [Full Text] [Related]
30. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee. Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424 [No Abstract] [Full Text] [Related]
31. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years. MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774 [No Abstract] [Full Text] [Related]
32. Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study. Woeste G; Wullstein C; Dette K; Pridöhl O; Lübke P; Bechstein WO Transplant Proc; 2002 Aug; 34(5):1920-1. PubMed ID: 12176629 [No Abstract] [Full Text] [Related]
33. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients. Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465 [No Abstract] [Full Text] [Related]
34. Low dosage of cyclosporine and increased occurrence of chronic rejection in heart-transplanted patients. Mamprin F; Gamba A; Fiocchi R; Merlo M; Senni M; Troise G; Binetti G; Motta T; Parma A; Ferrazzi P Transplant Proc; 1994 Oct; 26(5):2581-2. PubMed ID: 7940800 [No Abstract] [Full Text] [Related]
35. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine. Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214 [No Abstract] [Full Text] [Related]
36. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience. Adamson R; Obispo E; Dychter S; Dembitsky W; Moreno-Cabral R; Jaski B; Gordon J; Hoagland P; Moore K; King J; Andrews J; Rich M; Daily PO Transplant Proc; 1998 Jun; 30(4):1107-9. PubMed ID: 9636449 [No Abstract] [Full Text] [Related]
37. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation. Kitabayashi K; Munn SR; Sterioff S Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964 [No Abstract] [Full Text] [Related]
38. Evaluation of various immunosuppressive regimes in second renal transplants. Toronyi E; Remport A; Járay J; Máthé Z; Borka P; Perner F Transplant Proc; 2001 May; 33(3):2315-6. PubMed ID: 11377543 [No Abstract] [Full Text] [Related]
39. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation. Lindholm A; Albrechtsen D; Tufveson G; Karlberg I; Persson NH; Groth CG Transplantation; 1992 Oct; 54(4):624-31. PubMed ID: 1412754 [TBL] [Abstract][Full Text] [Related]
40. Early results after pediatric cardiac transplantation with triple immunosuppression therapy. Canter CE; Saffitz JE; Moorhead S; Gutierrez FR; Bolman RM; Spray TL Am J Cardiol; 1993 Apr; 71(11):971-5. PubMed ID: 8465791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]